Suppr超能文献

有外周动脉疾病患者的咨询干预和心血管事件:BIP 随机临床试验的事后分析。

Counseling Intervention and Cardiovascular Events in People With Peripheral Artery Disease: A Post Hoc Analysis of the BIP Randomized Clinical Trial.

机构信息

Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, Townsville, Australia.

Department of Vascular and Endovascular Surgery, Townsville University Hospital, Townsville, Australia.

出版信息

JAMA Surg. 2024 Nov 1;159(11):1262-1270. doi: 10.1001/jamasurg.2024.3083.

Abstract

IMPORTANCE

It is unclear whether counseling to promote walking reduces the risk of major adverse cardiovascular events (MACE) in people with peripheral artery disease (PAD).

OBJECTIVE

To test whether a counseling intervention designed to increase walking reduced the risk of MACE in patients with PAD.

DESIGN, SETTING, AND PARTICIPANTS: The BIP trial was a randomized clinical trial, with recruitment performed between January 2015 and July 2018 and follow-up concluded in August 2023. Participants with walking impairment due to PAD from vascular departments in the Australian cities of Brisbane, Sydney, and Townsville were randomly allocated 1:1 to the intervention or control group. Data were originally analyzed in March 2024.

INTERVENTION

Four brief counseling sessions aimed to help patients with the challenges of increasing physical activity.

MAIN OUTCOMES AND MEASURES

The primary outcome was the between-group difference in risk of MACE, which included myocardial infarction (MI), stroke, and cardiovascular death. The relationship between Intermittent Claudication Questionnaire (ICQ) scores, PAD Quality of Life (PADQOL) scores, and MACE was examined with Cox proportional hazard regression analyses.

RESULTS

A total of 200 participants were included, with 102 allocated to the counseling intervention (51.0%) and 98 to the control group (49.0%).Participants were followed up for a mean (SD) duration of 3.5 (2.6) years. Median (IQR) participant age was 70 (63-76) years, and 56 of 200 participants (28.0%) were female. A total of 31 individuals had a MACE (composed of 19 MIs, 4 strokes, and 8 cardiovascular deaths). Participants allocated to the intervention were significantly less likely to have a MACE than participants in the control group (10 of 102 participants [9.8%] vs 21 of 98 [21.4%]; hazard ratio [HR], 0.43; 95% CI, 0.20-0.91; P = .03). Greater disease-specific quality of life (QOL) scores at 4 months (ICQ: HR per 1-percentage point increase, 0.97; 95% CI, 0.95-0.99; P < .001; PADQOL factor 3 [symptoms and limitations in physical functioning]: HR per 1-unit increase, 0.91; 95% CI, 0.84-0.98; P = .01) and at 12 months (ICQ: HR per 1-percentage point increase, 0.97; 95% CI, 0.95-0.99; P = .003; PADQOL factor 3: HR per 1-unit increase, 0.91; 95% CI, 0.84-0.98; P = .02) were associated with a lower risk of MACE. In analyses adjusted for ICQ or PADQOL factor 3 scores at either 4 or 12 months, allocation to the counseling intervention was no longer significantly associated with a lower risk of MACE.

CONCLUSIONS AND RELEVANCE

This post hoc exploratory analysis of the BIP randomized clinical trial suggested that the brief counseling intervention designed to increase walking may reduce the risk of MACE, possibly due to improvement in QOL.

TRIAL REGISTRATION

anzctr.org.au Identifier: ACTRN12614000592640.

摘要

重要性

目前尚不清楚针对促进步行的咨询是否可以降低外周动脉疾病 (PAD) 患者发生主要不良心血管事件 (MACE) 的风险。

目的

检验旨在增加步行的咨询干预是否可以降低 PAD 患者的 MACE 风险。

设计、地点和参与者:BIP 试验是一项随机临床试验,于 2015 年 1 月至 2018 年 7 月期间招募参与者,并于 2023 年 8 月结束随访。来自澳大利亚布里斯班、悉尼和汤斯维尔血管科的因 PAD 而导致行走能力受损的患者被随机分配至干预组或对照组,比例为 1:1。原始数据分析于 2024 年 3 月进行。

干预

共进行了 4 次简短的咨询会议,旨在帮助患者应对增加身体活动的挑战。

主要结果和测量指标

主要结局是干预组与对照组之间 MACE 风险的差异,包括心肌梗死 (MI)、中风和心血管死亡。使用 Cox 比例风险回归分析检查了间歇性跛行问卷 (ICQ) 评分、PAD 生活质量 (PADQOL) 评分与 MACE 之间的关系。

结果

共纳入 200 名参与者,其中 102 名被分配至咨询干预组(51.0%),98 名被分配至对照组(49.0%)。参与者的平均(SD)随访时间为 3.5(2.6)年。参与者的中位(IQR)年龄为 70(63-76)岁,200 名参与者中有 56 名(28.0%)为女性。共有 31 人发生 MACE(由 19 例 MI、4 例中风和 8 例心血管死亡组成)。与对照组相比,接受干预的参与者发生 MACE 的可能性显著降低(102 名参与者中有 10 名 [9.8%] vs 98 名参与者中有 21 名 [21.4%];风险比 [HR],0.43;95%CI,0.20-0.91;P=0.03)。4 个月时疾病特异性生活质量 (QOL) 评分更高(ICQ:每增加 1 个百分点的 HR,0.97;95%CI,0.95-0.99;P<0.001;PADQOL 因子 3 [症状和身体功能受限]:每增加 1 个单位的 HR,0.91;95%CI,0.84-0.98;P=0.01)和 12 个月时更高(ICQ:每增加 1 个百分点的 HR,0.97;95%CI,0.95-0.99;P=0.003;PADQOL 因子 3:每增加 1 个单位的 HR,0.91;95%CI,0.84-0.98;P=0.02)与 MACE 风险降低相关。在调整了 4 个月或 12 个月时的 ICQ 或 PADQOL 因子 3 评分后的分析中,咨询干预的分配与 MACE 风险降低不再显著相关。

结论和相关性

本项对 BIP 随机临床试验的事后探索性分析表明,旨在增加步行的简短咨询干预可能会降低 MACE 的风险,这可能是由于 QOL 的改善所致。

试验注册

anzctr.org.au Identifier:ACTRN12614000592640。

相似文献

4
Exercise for intermittent claudication.间歇性跛行的运动疗法
Cochrane Database Syst Rev. 2017 Dec 26;12(12):CD000990. doi: 10.1002/14651858.CD000990.pub4.
7
Smoking cessation for secondary prevention of cardiovascular disease.戒烟对心血管疾病二级预防的作用。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2.
8
Cilostazol for intermittent claudication.西洛他唑用于间歇性跛行。
Cochrane Database Syst Rev. 2014 Oct 31;2014(10):CD003748. doi: 10.1002/14651858.CD003748.pub4.
9
Omega-3 fatty acids for intermittent claudication.ω-3 脂肪酸治疗间歇性跛行。
Cochrane Database Syst Rev. 2024 Oct 29;10(10):CD003833. doi: 10.1002/14651858.CD003833.pub5.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验